These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1102235)

  • 41. Comparative efficacy and safety of immediate-release and controlled-release hydralazine in black hypertensive patients.
    Adir J; Janda SM; Curry CL; Taylor RE; Poku CD; Rotenberg KS
    Clin Ther; 1987; 9(6):640-50. PubMed ID: 3326679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
    Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ; Peter RH
    N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of long-term hydralazine treatment on myocardial structure and expression of myosin isogenes in cardiac pressure overload in rats.
    Reddy DS; Singh M; Ganguly NK
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):261-71. PubMed ID: 8803958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
    Sharma C; Soni A; Gupta A; Verma A; Verma S
    Am J Obstet Gynecol; 2017 Dec; 217(6):687.e1-687.e6. PubMed ID: 28867601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of response to intravenous hydralazine in hypertension.
    Shepherd A; Lin MS; McNay J; Ludden T; Musgrave G
    Clin Pharmacol Ther; 1981 Dec; 30(6):773-81. PubMed ID: 7307426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive activity of cadralazine in experimental hypertensive rats.
    Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T
    Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Observation on the mechanism of renin release by hydralazine in hypertensive patients.
    Ueda H; Kaneko Y; Takeda T; Ikeda T; Yagi S
    Circ Res; 1970 Oct; 27():Suppl 2:201-6. PubMed ID: 4918551
    [No Abstract]   [Full Text] [Related]  

  • 50. [Slow-release hydralazine in the treatment of essential arterial hypertension].
    Moscovici H; Yasbeck Júnior P; Fadul Neto J
    Arq Bras Cardiol; 1982 Sep; 39(3):197-9. PubMed ID: 7186366
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical evaluation of the antihypertensive effect of metoprolol in combination with hydrochlorothiazide and hydralazine in an unselected hypertensive population.
    Tuomilehto J; Nissinen A; Honkavaara M
    Acta Cardiol; 1980; 35(4):289-301. PubMed ID: 7010854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antihypertensive effect of the association of a beta adrenergic blockader, a vasodilator and a diuretic in slightly uremic hypertensive patients].
    Actis E; Amato EA; Palmero HA; Rebora EH; Fernández Vidal JM
    Medicina (B Aires); 1978; 38(6 Pt 1):673-8. PubMed ID: 750859
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
    Ramsay LE; Parnell L; Waller PC
    Postgrad Med J; 1987 Feb; 63(736):99-103. PubMed ID: 3671250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
    Kardiologiia; 1985 Jan; 25(1):23-8. PubMed ID: 3981857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of clonidine on sympathetic nervous activity in hydralazine-treated hypertensive patients.
    Velasco M; Bertoncini H; Romero E; Urbina-Quintana A; Guevara J; Hernández-Pieretti O
    Eur J Clin Pharmacol; 1978 Jul; 13(5):317-20. PubMed ID: 352707
    [No Abstract]   [Full Text] [Related]  

  • 57. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
    Glazer N
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):561-72. PubMed ID: 4628678
    [No Abstract]   [Full Text] [Related]  

  • 58. Fetal premature atrial contractions associated with hydralazine.
    Lodeiro JG; Feinstein SJ; Lodeiro SB
    Am J Obstet Gynecol; 1989 Jan; 160(1):105-7. PubMed ID: 2912074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Should the acetylator phenotype be determined when prescribing hydralazine for hypertension?
    Ramsay LE; Silas JH; Ollerenshaw JD; Tucker GT; Phillips FC; Freestone S
    Eur J Clin Pharmacol; 1984; 26(1):39-42. PubMed ID: 6714290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
    Tuckman J; Messerli F; Hodler J
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():159s-61. PubMed ID: 4593561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.